Adenosine A1 and A3 receptors protect astrocytes from hypoxic damage

European Journal of Pharmacology
Olga BjörklundB B Fredholm

Abstract

Brain levels of adenosine are elevated during hypoxia. Through effects on adenosine receptors (A(1), A(2A), A(2B) and A(3)) on astrocytes, adenosine can influence functions such as glutamate uptake, reactive gliosis, swelling, as well as release of neurotrophic and neurotoxic factors having an impact on the outcome of metabolic stress. We have studied the roles of these receptors in astrocytes by evaluating their susceptibility to damage induced by oxygen deprivation or exposure to the hypoxia mimic cobalt chloride (CoCl(2)). Hypoxia caused ATP breakdown and purine release, whereas CoCl(2) (0.8 mM) mainly reduced ATP by causing cell death in human D384 astrocytoma cells. Further experiments were conducted in primary astrocytes prepared from specific adenosine receptor knock-out (KO) and wild type (WT) mice. In WT cells purine release following CoCl(2) exposure was mainly due to nucleotide release, whereas hypoxia-induced intracellular ATP breakdown followed by nucleoside efflux. N-ethylcarboxamidoadenosine (NECA), an unselective adenosine receptor agonist, protected from cell death following hypoxia. Cytotoxicity was more pronounced in A(1)R KO astrocytes and tended to be higher in WT cells in the presence of the A(1) receptor ...Continue Reading

References

Dec 28, 1976·Pflügers Archiv : European journal of physiology·J Schrader, E Gerlach
May 21, 1990·Brain Research·G A GregoryP H Chan
Feb 1, 1989·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A C YuP H Chan
Sep 22, 1994·European Journal of Pharmacology·D K Von LubitzK A Jacobson
Nov 7, 2000·Journal of Neuroimmunology·M E DorfY Luo
Jul 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·B JohanssonB B Fredholm
Jan 31, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Giulia ArslanBertil B Fredholm
Apr 23, 2002·Glia·Patrizia Di IorioMichel P Rathbone
Feb 3, 2004·Journal of Cellular and Molecular Medicine·T PearsonB G Frenguelli
Mar 11, 2004·Journal of Neurochemistry·Fiona E Parkinson, Wei Xiong
Mar 23, 2004·Current Molecular Medicine·Raymond A SwansonTiina M Kauppinen
Mar 26, 2005·Canadian Journal of Physiology and Pharmacology·R SouthworthP B Garlick
Apr 23, 2005·Glia·Kiran S Panickar, Michael D Norenberg
Oct 8, 2005·Science·Olivier PascualPhilip G Haydon
Oct 4, 2006·Journal of Neuroscience Research·Guann-Juh ChenYun Wang
Oct 24, 2006·Trends in Pharmacological Sciences·Detlev Boison
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Tianqing KongSean P Colgan
Mar 31, 2007·Cell Death and Differentiation·B B Fredholm
Jun 19, 2007·Physiology & Behavior·Elisabetta DaréBertil B Fredholm

❮ Previous
Next ❯

Citations

Mar 14, 2009·Molecular Neurobiology·Alexei VerkhratskyGeoffrey Burnstock
Feb 7, 2013·Neurochemistry International·Eleonora AronicaDetlev Boison
Jul 21, 2012·ACS Chemical Neuroscience·Davide GiustMairena Martín
Sep 19, 2009·Cell Death and Differentiation·D BoisonB B Fredholm
Dec 29, 2010·The Journal of Biological Chemistry·Christine SchieberSeong-Seng Tan
Mar 30, 2010·Acta Physiologica·G BurnstockA Verkhratsky
Jul 1, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Bo-Syong PanBu-Miin Huang
Jul 13, 2013·FEBS Open Bio·Laurent JacquinJean Ruf
Sep 13, 2011·Progress in Neurobiology·Geoffrey BurnstockPeter Illes
Apr 20, 2010·Chemico-biological Interactions·Sandra CeccatelliMichaela Moors
Jul 8, 2010·Glia·Tobias B KulikH Richard Winn
May 23, 2013·Acta Physiologica·A Corcoran, J J O'Connor
Dec 7, 2013·Glia·Estíbaliz González-FernándezCarlos Matute
Nov 20, 2015·Neuropharmacology·Felicita PedataAnna Maria Pugliese
Mar 27, 2013·The International Journal of Neuroscience·Hao LiuFa-Fa Tian
Aug 24, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Stefania GessiPier Andrea Borea
Mar 18, 2015·Experimental and Therapeutic Medicine·Teodora AlexaCatalina Roxana Bohotin
Feb 25, 2017·Journal of Cellular Physiology·Mohammad H KazemiFarhad Jadidi-Niaragh
Feb 24, 2016·Brain Sciences·Gatambwa MukandalaJohn J O'Connor
May 10, 2018·The Journal of Physiology·Jan Marino RamirezIbis M Agosto-Marlin
Oct 14, 2018·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Troy A Hackett
Mar 4, 2018·Pharmacological Reviews·Sascha R A Alles, Peter A Smith
Nov 13, 2014·Pharmacological Reviews·Pier Andrea BoreaStefania Gessi
Jan 20, 2018·Physiological Reviews·Alexei Verkhratsky, Maiken Nedergaard
Jun 17, 2016·Journal of Asian Natural Products Research·Yi-Xi YangHai-Sheng Chen
Sep 29, 2020·Therapeutic Hypothermia and Temperature Management·Dongyang MaShan Zhang
Mar 17, 2018·Frontiers in Pharmacology·Marija Adzic, Nadezda Nedeljkovic
Dec 8, 2020·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Joana I GomesSandra H Vaz
Mar 21, 2020·Journal of the Neurological Sciences·Meiying XinDi Ma
Mar 18, 2021·Cellular and Molecular Neurobiology·D Pereira-FigueiredoK C Calaza
Dec 18, 2020·Biochemical Pharmacology·Cátia R LopesPaula M Canas
Jun 14, 2021·Molecular Neurobiology·Zeinab VahidiniaAbolfazl Azami Tameh
Nov 23, 2021·Stroke; a Journal of Cerebral Circulation·Theodore E ListonJames D Lechleiter

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis